The analysis also found that a handful of commonly used, high-priced cancer drugs are driving doctors’ and hospitals’ income under the current payment model.
Read the full article here.
The analysis also found that a handful of commonly used, high-priced cancer drugs are driving doctors’ and hospitals’ income under the current payment model.
Read the full article here.